[go: up one dir, main page]

NO20000111L - Fremstilling av oksymorfon, oksykodon og derivater derav - Google Patents

Fremstilling av oksymorfon, oksykodon og derivater derav

Info

Publication number
NO20000111L
NO20000111L NO20000111A NO20000111A NO20000111L NO 20000111 L NO20000111 L NO 20000111L NO 20000111 A NO20000111 A NO 20000111A NO 20000111 A NO20000111 A NO 20000111A NO 20000111 L NO20000111 L NO 20000111L
Authority
NO
Norway
Prior art keywords
derivatives
oxymorphone
oxycodone
preparation
noroxymorphone
Prior art date
Application number
NO20000111A
Other languages
English (en)
Other versions
NO20000111D0 (no
Inventor
Bao-Shan Huang
Aris P Christodoulou
Yansong Lu
Ben-Yi Ji
Original Assignee
Penick Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25401603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20000111(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Penick Corp filed Critical Penick Corp
Publication of NO20000111D0 publication Critical patent/NO20000111D0/no
Publication of NO20000111L publication Critical patent/NO20000111L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Det er beskrevet fremgangsmåter for omdanningen av normofinon og dets derivater, som kan syntetiseres fra morfin, til det tilsvarende 14-hydroksynormor-finonet og dets derivater omfattende oksykodon, oksymorfon, noroksymorfon og naltrekson. Noroksymorfon er et nøkkelmellomprodukt for fremstillingen av viktige narkotiske analgesiske midler og antagonister. Det er videre beskrevet visse nye mellomprodukter.
NO20000111A 1997-07-11 2000-01-10 Fremstilling av oksymorfon, oksykodon og derivater derav NO20000111L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/893,464 US5869669A (en) 1996-07-26 1997-07-11 Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
PCT/US1998/013592 WO1999002529A1 (en) 1997-07-11 1998-07-10 Preparation of oxymorphone, oxycodone and derivatives

Publications (2)

Publication Number Publication Date
NO20000111D0 NO20000111D0 (no) 2000-01-10
NO20000111L true NO20000111L (no) 2000-02-25

Family

ID=25401603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000111A NO20000111L (no) 1997-07-11 2000-01-10 Fremstilling av oksymorfon, oksykodon og derivater derav

Country Status (20)

Country Link
US (7) US5869669A (no)
EP (1) EP1000065B1 (no)
JP (1) JP2001518444A (no)
KR (1) KR100363486B1 (no)
CN (1) CN1152880C (no)
AT (1) ATE291023T1 (no)
AU (1) AU740822B2 (no)
CA (1) CA2296035C (no)
DE (1) DE69829379D1 (no)
HK (1) HK1028025A1 (no)
HU (1) HUP0003918A3 (no)
IL (1) IL133792A0 (no)
IN (1) IN1998KO01500A (no)
NO (1) NO20000111L (no)
RU (1) RU2183636C2 (no)
SK (1) SK102000A3 (no)
TR (1) TR200000033T2 (no)
TW (1) TW505648B (no)
WO (1) WO1999002529A1 (no)
ZA (1) ZA986144B (no)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912347A (en) * 1996-09-30 1999-06-15 Mallinckrodt Inc. Process for preparing a morphinan derivative
WO2000066588A1 (en) * 1999-05-05 2000-11-09 The Government Of The United States Of America, Represented By The Secretary, Departmentof Health A Nd Human Services Direct c-14 oxidation of opioids
US6177567B1 (en) * 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
WO2003018588A2 (en) * 2001-08-23 2003-03-06 Akzo Nobel N.V. Process for the preparation of a 14-hydroxynormorphinone derivative
JP3961796B2 (ja) * 2001-08-27 2007-08-22 ソニー株式会社 情報提供システム、情報処理装置および方法、情報提供装置および方法、記録媒体、並びにプログラム
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US20040058946A1 (en) * 2002-07-05 2004-03-25 Buchwald Stephen L. Abuse-resistant prodrugs of oxycodone and other pharmaceuticals
JP2006509745A (ja) * 2002-11-08 2006-03-23 マリンクロッド・インコーポレイテッド 第四級ｎ−アルキルモルフィナンアルカロイド塩の製造方法
CA2779723C (en) * 2002-12-13 2014-03-25 Durect Corporation Oral drug delivery system
US6790959B1 (en) 2003-06-05 2004-09-14 Halsey Drug Company, Inc. Process for manufacturing thebaine
US6864370B1 (en) 2003-06-05 2005-03-08 Zhaiwei Lin Process for manufacturing oxycodone
EP1664061B1 (en) 2003-09-22 2017-03-15 GlaxoSmithKline Australia Pty Ltd Process for the synthesis of morphinane compounds and intermediates thereof
US7875718B2 (en) * 2003-09-22 2011-01-25 Johnson Matthey Public Limited Company Process for the synthesis of morphinane compounds and intermediates thereof
GEP20084454B (en) 2004-02-06 2008-08-10 Euro Celtique Sa Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
TW201509943A (zh) * 2004-03-30 2015-03-16 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
SK286047B6 (sk) * 2004-04-13 2008-01-07 Zentiva, A. S. Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
US6946556B1 (en) * 2004-05-21 2005-09-20 Acura Pharmaceuticals, Inc. Preparation of opioid analgesics by a one-pot process
EP1758908A1 (en) * 2004-06-08 2007-03-07 Mallinckrodt, Inc. Extraction of alkaloids from opium
DK1765292T3 (en) 2004-06-12 2018-01-02 Collegium Pharmaceutical Inc ABUSE PREVENTIONAL PHARMACEUTICAL FORMULATIONS
PL2415484T3 (pl) 2004-09-17 2014-11-28 Durect Corp Kompozycja znieczulająca miejscowo o przedłużonym uwalnianiu zawierająca SAIB
GB0421149D0 (en) * 2004-09-23 2004-10-27 Johnson Matthey Plc Preparation of oxycodone
GB0421687D0 (en) † 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
WO2006084389A1 (de) * 2005-02-11 2006-08-17 Cilag Ltd. Verfahren zur reinigung von noroxymorphon-verbindungen
PT2112153E (pt) * 2005-03-04 2010-12-17 Euro Celtique Sa Método de diminuír a quantidade de cetonas insaturadas em alfa-beta em composições de opiáceos
US8071768B2 (en) * 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
EP1893616B1 (en) * 2005-06-16 2010-12-29 Mallinckrodt, Inc. A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
US8871779B2 (en) 2006-03-02 2014-10-28 Mallinckrodt Llc Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
CA2663909A1 (en) * 2006-09-20 2008-03-27 Mallinckrodt Inc. Preparation of substituted morphinan-6-ones and salts and intermediates thereof
CA2674915C (en) 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
WO2008048711A1 (en) * 2006-10-17 2008-04-24 Penick Corporation Process for preparing oxymorphone
US20080125592A1 (en) * 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
AU2012216358B2 (en) * 2006-10-17 2014-11-20 Penick Corporation Process For Preparing Oxymorphone, Naltrexone and Buprenorphine
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
ES2378710T3 (es) * 2006-12-04 2012-04-17 Noramco, Inc. Procedimiento para reducir impurezas en la base de oxicodona
WO2008070658A1 (en) * 2006-12-04 2008-06-12 Noramco, Inc. Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
US9040726B2 (en) 2007-03-06 2015-05-26 Mallinckrodt Llc Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
EP2147920B1 (en) * 2007-03-06 2016-08-31 Mallinckrodt LLC Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
EP2125824B2 (en) * 2007-03-23 2023-11-15 Mallinckrodt LLC Improved preparation of oxymorphone from oripavine
WO2008130553A1 (en) * 2007-04-16 2008-10-30 Mallinckrodt Inc. Novel opiate reduction utilizing catalytic hydrogen transfer reaction
US20090018154A1 (en) * 2007-05-17 2009-01-15 Endo Pharmaceuticals, Inc., A Corporation Of Delaware Opioid and methods of making and using the same
AU2008335809A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
CA2709862C (en) 2007-12-17 2016-03-15 Peter X. Wang Sinomenine derivatives and processes for their synthesis
CA2709886C (en) * 2007-12-17 2016-10-25 Mallinckrodt Inc. Processes for the production of (+)-"nal" morphinan compounds
ATE519765T1 (de) 2008-02-29 2011-08-15 Mallinckrodt Inc Verfahren zur herstellung von 3-hydroxymorphinan- derivaten
PT2291380E (pt) * 2008-04-24 2011-12-22 Janssen Pharmaceutica Nv Pró-fármacos nalmefeno
EP2896614B1 (en) * 2008-05-27 2017-07-12 Mallinckrodt LLC Processes and compounds for the preparation of normorphinans
WO2010028004A2 (en) 2008-09-03 2010-03-11 Mallinckrodt Inc. Substituted berbines and processes for their synthesis
US8080661B2 (en) * 2008-09-30 2011-12-20 Mallinckrodt Llc Processes for the synthesis of tertiary amines
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
UA102916C2 (uk) 2009-07-02 2013-08-27 Кемфарм, Інк. Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2011154826A1 (en) 2010-06-11 2011-12-15 Rhodes Technologies Process for n-dealkylation of tertiary amines
AU2011263417B2 (en) 2010-06-11 2014-03-27 Rhodes Technologies Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof
GB2495062A (en) 2010-07-02 2013-03-27 Johnson Matthey Plc Process for the synthesis and purification of oxycodone
RU2448709C1 (ru) * 2011-02-01 2012-04-27 Учреждение Российской академии наук Институт проблем химико-энергетических технологий Сибирского отделения РАН (ИПХЭТ СО РАН) Способ получения налтрексона
TWI560170B (en) * 2011-12-06 2016-12-01 Lundbeck & Co As H Process for recovery of nalmefene hydrochloride
US9315514B2 (en) 2012-08-27 2016-04-19 Rhodes Technologies 1,3-dioxanomorphides and 1,3-dioxanocodides
US8980906B2 (en) 2012-12-14 2015-03-17 Purdue Pharma L.P. Pyridonemorphinan analogs and biological activity on opioid receptors
WO2014091297A1 (en) 2012-12-14 2014-06-19 Purdue Pharma L.P. Spirocyclic morphinans and their use
EP2931725B1 (en) 2012-12-14 2017-02-15 Purdue Pharma LP Nitrogen containing morphinan derivatives and the use thereof
US8946255B2 (en) 2012-12-28 2015-02-03 Purdue Pharma L.P. Substituted morphinans and the use thereof
WO2014102587A1 (en) 2012-12-28 2014-07-03 Purdue Pharma L.P. 7,8-cyclicmorphinan analogs
WO2014102591A1 (en) 2012-12-31 2014-07-03 Rhodes Technologies PROCESS FOR PREPARING 7β-SUBSTITUTED 6α,14α -ETHENOMORPHINANS AND 7β-SUBSTITUTED 6α,14α-ETHANOMORPHINANS
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
EP2829541A1 (en) 2013-07-26 2015-01-28 Siegfried AG Novel synthesis of noroxymorphone from morphine
WO2015015146A1 (en) 2013-08-02 2015-02-05 Johnson Matthey Public Limited Company Process for the preparation of oxymorphone
US9994571B2 (en) 2013-12-26 2018-06-12 Purdue Pharma L.P. 10-substituted morphinan hydantoins
US9340542B2 (en) 2013-12-26 2016-05-17 Purdue Pharma L.P. Propellane-based compounds and the use thereof
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
US9988392B2 (en) 2013-12-26 2018-06-05 Purdue Pharma L.P. 7-beta-alkyl analogs of orvinols
US9902726B2 (en) 2013-12-30 2018-02-27 Purdue Pharma L.P. Pyridone-sulfone morphinan analogs as opioid receptor ligands
NZ731591A (en) 2014-11-25 2018-06-29 Kempharm Inc Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone
ES2701855T3 (es) 2016-05-31 2019-02-26 Alcaliber Investig Desarrollo E Innovacion Slu Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
SI3559010T1 (sl) 2016-12-23 2022-10-28 Minoryx Therapeutics S. L. Postopek za pripravo 5-((4-(2-(5-(1-hidroksietil)-2-piridinil)etoksi) fenil)metil)-2,4-tiazolidindiona in soli le-tega
SK592017A3 (sk) 2017-07-04 2019-01-08 Saneca Pharmaceuticals A. S. Spôsob prípravy morfínanových zlúčenín
JP7284764B2 (ja) 2018-02-23 2023-05-31 ロデス テクノロジーズ 新規オピオイド化合物及びその使用
CN110054656B (zh) * 2019-05-28 2021-02-02 宜昌人福药业有限责任公司 一种10-羰基/羟基吗啡-6-葡萄糖苷酸的合成方法
CA3146163A1 (en) 2019-07-08 2021-01-14 University Of Health Sciences & Pharmacy In St. Louis G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819636A (en) * 1970-09-15 1974-06-25 American Home Prod 4a,10-(methaniminomethano)phenanthrene derivatives
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5112975A (en) * 1984-03-27 1992-05-12 Mallinckrodt Specialty Chemicals Company Preparation of noroxymorphone from morphine
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US4912114A (en) * 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives

Also Published As

Publication number Publication date
JP2001518444A (ja) 2001-10-16
ZA986144B (en) 1999-05-19
US5922876A (en) 1999-07-13
US5869669A (en) 1999-02-09
HK1028025A1 (en) 2001-02-02
US6013796A (en) 2000-01-11
CN1152880C (zh) 2004-06-09
CN1272845A (zh) 2000-11-08
CA2296035A1 (en) 1999-01-21
SK102000A3 (en) 2000-07-11
WO1999002529A1 (en) 1999-01-21
HUP0003918A3 (en) 2003-04-28
US6008354A (en) 1999-12-28
CA2296035C (en) 2004-04-13
EP1000065A1 (en) 2000-05-17
US6008355A (en) 1999-12-28
DE69829379D1 (de) 2005-04-21
NO20000111D0 (no) 2000-01-10
US5952495A (en) 1999-09-14
AU740822B2 (en) 2001-11-15
IN1998KO01500A (no) 2005-03-11
TR200000033T2 (tr) 2000-12-21
TW505648B (en) 2002-10-11
US5948788A (en) 1999-09-07
IL133792A0 (en) 2001-04-30
KR20010021693A (ko) 2001-03-15
ATE291023T1 (de) 2005-04-15
EP1000065B1 (en) 2005-03-16
EP1000065A4 (en) 2001-09-12
KR100363486B1 (ko) 2002-12-16
AU8379198A (en) 1999-02-08
HUP0003918A2 (hu) 2001-07-30
RU2183636C2 (ru) 2002-06-20

Similar Documents

Publication Publication Date Title
NO20000111L (no) Fremstilling av oksymorfon, oksykodon og derivater derav
ES2239170T3 (es) 2,6-metano-3-benzazocinas sustituidas en posicion 8 y morfinanos sustituidos en posicion 3 como agentes ligantes a receptores opioides.
WO2004045551A3 (en) Pharmaceutical composition
EP1053238A4 (en) THERAPEUTIC CONNECTIONS
AU2002227135A1 (en) 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
GB0200245D0 (en) Method of producing organic light-emissive devices
WO2004005294A3 (de) Morphinanderivate und deren quartäre ammoniumsalze substituiert in position 14, herstellungsverfahren und verwendung
WO2004108090A3 (en) Process for manufacturing oxycodone
MX2007005389A (es) 4-hidroxibenzomorfanos.
WO2000071518A3 (en) Heterocyclic analgesic compounds and their use
NZ331119A (en) Isoquinolines useful as analgesics
EP0496830B1 (en) Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
WO2001029046A3 (en) A salt of morphine
NO992587D0 (no) FremgangsmÕte for fremstilling av en spolbar kveilr°rstreng
NO981131L (no) Diarylalkenylamin-derivater
CA2256007A1 (en) Substituted heterocyclic benzocycloalkenes and their use as analgesic
HK1075452A1 (en) Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl - methanone derivatives, methods for production and use thereof as medicaments
GB2368238B (en) A method of searching a code space
SE9802939D0 (sv) New process
AU3813501A (en) Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
NO20023210L (no) Fremgangsmåte for fremstilling av en presset, ufölsom sprengstoffblanding
GB0004162D0 (en) Improved preparation of morphine opiate alkaloids from poppy straw
HK1049654A1 (zh) 通過催化脫氫製備二苯並環庚烯酮的衍生物
PL343290A1 (en) Method of obtaining diastereoisometric mixture of cyclic etheric compounds, mixture of such compounds obtaining thereby, mixture of salts of lic etheric compounds and novel intermediate compounds
HK1028346A1 (en) Topical application of opioid analgesic drugs suchas morphine.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application